Sponsor Pipeline

Coya Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07161999
Study of COYA 302 for the Treatment of ALS		 Phase changed: Phase 2 -> Phase 2/3
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07161999 Study of COYA 302 for the Treatment of ALS Amyotrophic Lateral Sclerosis (ALS) Recruiting
Disease Areas
ALS (1)
Get alerts when Coya Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free